MiniMed Group, Inc. 8-K

What Happened
MiniMed Group, Inc. announced that Brett Wall, a Class II director and member of the Nominating and Corporate Governance Committee, will resign from the board effective July 3, 2026. Mr. Wall’s resignation follows his departure as Executive Vice President and President, Neuroscience Portfolio, of Medtronic plc, and is not due to any disagreement with MiniMed’s management or board. On May 18, 2026, MiniMed appointed Scott Cundy, a Medtronic Senior Vice President and Chief Quality, Development, and Innovation Officer, to fill the vacancy effective July 3, 2026; Mr. Cundy will serve as a Class II director through the 2027 annual meeting and will join the Nominating and Corporate Governance Committee.

Key Details

• Brett Wall will resign effective July 3, 2026; resignation is not related to any disagreement with the company.
• Scott Cundy was appointed May 18, 2026 to begin service July 3, 2026 as a Class II director; his term expires at the 2027 annual meeting.
• Mr. Cundy currently serves on the Medtronic Executive Committee and leads Global Quality, Product Development, and Innovation; prior role at Danaher and holds a B.S. (Georgia Tech) and an MBA (University of Minnesota).
• While Medtronic remains an affiliate of MiniMed, Mr. Cundy—an employee of Medtronic—will receive no board compensation; future director pay will align with MiniMed’s non-employee director policy.

Why It Matters
This 8‑K documents a board change that maintains Medtronic’s representation on MiniMed’s board through another senior Medtronic executive, ensuring continuity in governance and oversight tied to the parent company. Investors should note the effective date (July 3, 2026), the limited term through the 2027 annual meeting, and that the appointment does not involve additional director compensation while Medtronic is an affiliate.